FDA 483 - King Pharmaceuticals LLC - October 21, 2019

Kind Pharmaceuticals, LLC. in Rochester, MI, was inspected and cited for a single observation related to its quality control unit. The firm failed to fully follow its own procedures for cleaning validation, specifically by not applying required correction factors from swab recovery studies during re-qualification. This indicates a deficiency in adhering to established quality control processes.